Is Monural withdrawn from the market?

Only Monural in 2 g sachets was withdrawn from the market, while the drug in 3 g sachets remained on the market. The European Medicines Agency (EMA) recommended that fosfomycin (the active ingredient in Monural) be discontinued in children under 12 years of age and Monural 2 g was indicated for use in children over 5 years of age and was therefore withdrawn from the market. The drug in 3 g sachets is indicated for use only in people over 12 years of age, therefore it remained on the market. Monural contains an antibiotic - fosfomycin and is indicated, m.in. in the treatment of bacterial cystitis, abundant asymptomatic bacteriuria and in the prevention of urinary tract infections associated with surgical procedures and transurethral diagnostic procedures. More information about the drug: https://www.gdziepolek.pl/produkty/50320/monural-granulat-do-wytworzenia-plynu/apteki I enclose a helpful article: https://www.gdziepolek.pl/blog/leki-wstrzymane-i-wycofane-z-obrotu